1183 studies found for:    Open Studies | "Genital Diseases, Male"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Genital Diseases, Male"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Not yet recruiting Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Conditions: Spinal Cord Injury;   Spinal Cord Injuries;   Trauma, Nervous System;   Wounds and Injuries;   Central Nervous System Diseases;   Nervous System Diseases;   Spinal Cord Diseases;   Gonadal Disorders;   Endocrine System Diseases;   Hypogonadism;   Genital Diseases, Male
Interventions: Drug: testosterone enanthate, finasteride;   Other: placebo
3 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
4 Recruiting Mecillinam for Treatment of Genital Chlamydia Infection
Conditions: Chlamydia Trachomatis Infection;   Chlamydial Urethritis
Intervention: Drug: Pivmecillinamhydrochlorid
5 Unknown  PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor;   Adenocarcinoma of the Colon;   Adenocarcinoma of the Rectum;   Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Benign Teratoma;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Familial Testicular Germ Cell Tumor;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Male Breast Cancer;   Ovarian Immature Teratoma;   Ovarian Mature Teratoma;   Ovarian Monodermal and Highly Specialized Teratoma;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Extragonadal Germ Cell Tumor;   Recurrent Extragonadal Non-seminomatous Germ Cell Tumor;   Recurrent Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Melanoma;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Rectal Cancer;   Stage III Extragonadal Non-seminomatous Germ Cell Tumor;   Stage III Extragonadal Seminoma;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Ovarian Germ Cell Tumor;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Extragonadal Non-seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Melanoma;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Rectal Cancer;   Testicular Immature Teratoma;   Testicular Mature Teratoma
Interventions: Drug: PD-0332991;   Other: pharmacological study
6 Recruiting Fuse Image MRI Guided Prostate Cryotherapy
Conditions: Neoplasms Prostate;   Cancer of the Prostate
Intervention: Procedure: FUSE IMAGE MRI GUIDED PROSTATE CRYOTHERAPY
7 Recruiting Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
Conditions: Prostate Cancer;   Radiation Therapy
Interventions: Dietary Supplement: Curcumin;   Dietary Supplement: Placebo
8 Unknown  A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury
Condition: Erectile Dysfunction
Interventions: Drug: Vardenafil;   Drug: Placebo
9 Recruiting Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Cabozantinib;   Drug: Androgen Ablation Therapy
10 Not yet recruiting Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz
Condition: Prostate Cancer Metastatic
Interventions: Drug: CABAZITAXEL XRP6258;   Drug: Enzalutamide;   Drug: Abiraterone acetate;   Drug: Prednisone
11 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
12 Recruiting Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: S-equol;   Drug: Placebo
13 Recruiting Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device
Condition: Prostate Cancer
Intervention:
14 Recruiting Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Condition: Prostate Cancer
Intervention: Radiation: CyberKnife Boost
15 Recruiting Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
16 Not yet recruiting Syphilis Treatment of Partners Trial
Condition: Syphilis Infection
Intervention: Procedure: Partner Notification Reminders
17 Not yet recruiting Dual Protection Project
Condition: Teen Sexual Health
Intervention: Behavioral: text message intervention
18 Unknown  ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma
Condition: Prostate Adenocarcinoma
Interventions: Radiation: external  radiotherapy;   Drug: Acide zoledronic
19 Unknown  A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Epirubicin;   Drug: Estramustine Phosphate;   Drug: Celecoxib
20 Not yet recruiting Rilimogene-Galvacirepvec in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Conditions: Prostate Adenocarcinoma;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Biological: Rilimogene-galvacirepvec

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years